000			01987 a2200529 4500
005			20250518085330.0
264		0	_c20210420
008			202104s 0 0 eng d
022			_a1472-8206
024	7		_a10.1111/fcp.12549 _2doi
040			_aNLM _beng _cNLM
100	1		_aEl-Sisi, Alaa E
245	0	0	_aTargeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity. _h[electronic resource]
260			_bFundamental & clinical pharmacology _cAug 2020
300			_a458-475 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aATP Binding Cassette Transporter, Subfamily B, Member 1 _xgenetics
650	0	4	_aAnimals
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xchemistry
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aCarcinoma, Ehrlich Tumor _xdrug therapy
650	0	4	_aCardiotoxicity
650	0	4	_aCaspase 3 _xmetabolism
650	0	4	_aDrug Carriers
650	0	4	_aDrug Compounding
650	0	4	_aFemale
650	0	4	_aHeart Diseases _xchemically induced
650	0	4	_aHumans
650	0	4	_aImatinib Mesylate _xchemistry
650	0	4	_aIndoles _xchemistry
650	0	4	_aKi-67 Antigen _xmetabolism
650	0	4	_aMCF-7 Cells
650	0	4	_aMice
650	0	4	_aNanoparticles
650	0	4	_aPolylactic Acid-Polyglycolic Acid Copolymer _xchemistry
650	0	4	_aProto-Oncogene Proteins c-bcl-2 _xmetabolism
650	0	4	_aSignal Transduction
650	0	4	_aSulfonamides _xchemistry
650	0	4	_aTumor Burden _xdrug effects
650	0	4	_abcl-2-Associated X Protein _xmetabolism
700	1		_aSokkar, Samia S
700	1		_aIbrahim, Hanaa A
700	1		_aHamed, Mohamed F
700	1		_aAbu-Risha, Sally E
773	0		_tFundamental & clinical pharmacology _gvol. 34 _gno. 4 _gp. 458-475
856	4	0	_uhttps://doi.org/10.1111/fcp.12549 _zAvailable from publisher's website
999			_c30656803 _d30656803